Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Pfizer to Buy OTC Rights to Nexium for $250 Million Upfront
Aug. 15, 2012
Pfizer has agreed to acquire rights to market AstraZeneca’s popular heartburn drug Nexium for OTC use, paying $250 million up front as well as milestone and royalty payments.
The Wall Street Journal
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing